Dominique Douguet Selected Research

panicein A

6/2020

Inhibition of Patched Drug Efflux Increases Vemurafenib Effectiveness against Resistant BrafV600E Melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dominique Douguet Research Topics

Disease

4	Pain (Aches) 01/2021 - 10/2012
2	Malaria 04/2015 - 02/2013
1	Melanoma (Melanoma, Malignant) 06/2020
1	Neoplasms (Cancer) 06/2020
1	Renal Insufficiency (Renal Failure) 01/2019
1	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2019
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 01/2019
1	Cysts 01/2019
1	Nervous System Diseases (Neurological Disorders) 02/2016
1	Mental Disorders (Mental Disorder) 05/2014
1	Intellectual Disability (Idiocy) 05/2011

Drug/Important Bio-Agent (IBA)

4	Acid Sensing Ion ChannelsIBA 01/2021 - 10/2012
4	Peptides (Polypeptides)IBA 01/2021 - 10/2012
2	Snake Venoms (Snake Venom)IBA 01/2021 - 10/2012
2	Protons (Proton)IBA 01/2021 - 05/2014
2	VenomsIBA 02/2016 - 10/2012
2	Phosphatidylcholines (Phosphatidylcholine)IBA 04/2015 - 02/2013
1	Three Finger ToxinsIBA 01/2021
1	hydroquinone (Esoterica)FDA Link 06/2020
1	panicein AIBA 06/2020
1	VemurafenibIBA 06/2020
1	TRPP Cation ChannelsIBA 01/2019
1	LipidsIBA 04/2015
1	CationsIBA 05/2014
1	Membrane LipidsIBA 02/2013
1	phosphatidylethanolamineIBA 02/2013
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 05/2011

Therapy/Procedure

1	Analgesia 10/2012